Innovative solutions to
keep your project on course

Scientific Writing

Whether it is a clinical site interpreting a protocol, a peer reviewer deciding whether your manuscript should be accepted into a prestigious journal, or a regulatory agency reviewing your IND, it is important that your message is conveyed in a way that is clear, impactful, and appropriately written for your target audience.

Nuventra’s consultants bring to bear many years of scientific, medical, and regulatory writing experience to meet our clients’ needs. Our consultants have experience authoring a diverse array of documents for submission to the FDA and other regulatory agencies, as well as scientific manuscripts for submission to peer-reviewed journals.

In addition to the experience of our consultants, Nuventra has critical infrastructure in place to ensure that the documents we deliver to our clients are of the highest caliber. We have robust document templates and medical writing SOPs coupled with a rigorous quality control (QC) process to allow for production of high quality, submission-ready documents.

Our Scientific Writing Services:

  • Pharmacokinetics/pharmacodynamics (PK/PD), toxicokinetics (TK), and population PK reports
  • Clinical pharmacology study protocol
  • Clinical study report (CSR)
  • Investigational New Drug (IND) Application
  • New Drug Application (NDA)
  • Biologics License Application (BLA)
  • FDA meeting request and briefing package
  • Orphan drug application
  • Pediatric Study Plan (PSP)
  • Medical manuscript or journal article

Explore Our Blog

Programs to Promote Drug Development for Rare Diseases

Until the early 1980s, developing therapeutics to treat rare diseases was most often a money-losing endeavor due to high cost…

Read More

7 Pitfalls to Avoid in Your Next Phase 1 Study

Study design and subject safety are of the utmost importance in a Phase 1 study. It is also important to…

Read More

A Winning Combination: Efficient Drug Development for Combination Products

In a previous post, we discussed how combination products are defined in the Code of Federal Regulations, introduced FDA’s Office of Combination Products,…

Read More